Technical analysis of Oruka Therapeutics, Inc. (ORKA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.
Price Performance
| 1 month | +17.98% |
| 3 months | +1.15% |
| Year-to-date | +228.44% |
| 1 year | +262.92% |
| 3 years | +336.62% |
| 5 years | +215.43% |
| 10 years | -79.52% |
52-Week Range
| 52-week High | $115.52 |
| 52-week Low | $25.23 |
| Avg Volume (90d) | 980K |
Technical Indicators
| SMA 50 | $88.17 |
| SMA 200 | $69.88 |
| Beta | -0.61 |
| 30-day Volatility (annualised) | 59.5% |
| Price vs SMA 50 | +12.9% |
| Price vs SMA 200 | +42.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $30.31 | |
| 2026-01 | $34.23 | +12.9% |
| 2026-02 | $34.41 | +0.5% |
| 2026-03 | $49.05 | +42.5% |
| 2026-04 | $68.41 | +39.5% |
| 2026-05 | $58.53 | -14.4% |
| 2026-06 | $95.17 | +62.6% |
| 2026-07 | $96.51 | +1.4% |
| 2026-08 | $92.62 | -4.0% |
| 2026-09 | $83.29 | -10.1% |
| 2026-10 | $96.87 | +16.3% |
| 2026-11 | $99.55 | +2.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-11 | $-0.60 | |
| 2026-08-10 | $-0.51 | |
| 2026-05-13 | $-0.55 | |
| 2026-03-12 | $-0.61 | |
| 2025-11-12 | $-0.56 | |
| 2025-08-11 | $-0.48 | |
| 2025-05-14 | $-0.57 | |
Price
| Price | $99.55 (closing price, November 3, 2026) |
| Market Cap | $6.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 5.62 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 38.51 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 49.15 |